Christopher Daugherty to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications Christopher Daugherty has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.207
-
Ethical issues in the development of new agents. Invest New Drugs. 1999; 17(2):145-53.
Score: 0.137
-
An intervention to improve cancer patients' understanding of early-phase clinical trials. IRB. 2009 May-Jun; 31(3):1-10.
Score: 0.070